Affiliation: | a The William Harvey Researxh Institute, St. Bartholomew's Medical College, London, EC1M 6BQ, UK b Department of Clinical Pharmacology, Royal Postgraduate Medical School, London, W12 0NN, UK c Department of Pharmacology, Cornell University Medical College, 1300 York Avenue, New York, NY, 10021, USA |
Abstract: | Septic or inflammatory stimuli suppress drug metabolism by cytochrome P-450 in the liver, presumably at the pretranslational level. We have shown previously that nitric oxide is responsible at least in part for the inhibition by bacterial lipopolysaccharide of phenobarbital-induced CYP2B1/2 activity in vivo. This was attributed to the interaction of nitric oxide with heme in the active-center of cytochrome P450, leading to enzyme inactivation. Here, we report of nitric oxide with heme in the active-center of cytochrome P450, leading to enzyme inactivation. Here, we report that endogeneous nitric oxide also contributes to LPS-induced suppression of CYP2B1/2 in vivo by down-regulating the expression of CYP2B1/2 protein and mRNA. |